Literature DB >> 20370687

Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.

Zhe Wang1, Hyo-Jeong Lee, Yubo Chai, Hongbo Hu, Lei Wang, Yong Zhang, Cheng Jiang, Junxuan Lü.   

Abstract

The induction of G(1) cell cycle arrest and apoptosis by second-generation selenium compounds (e.g., methylselenol precursors such as methylseleninic acid, MSeA) may contribute to their anti-cancer activities. We have documented previously induction of G(1) arrest and apoptosis by MSeA in association with upregulation of cyclin-dependent kinase inhibitor (CDKI) proteins p21Cip1 and/or p27Kip1 in DU145 prostate cancer cells. However, whether these CDKIs play a critical mediator role in G(1) arrest and apoptosis by MSeA has not been addressed. In the present work, we show exposure of p53-mutant DU145 cells to sub-apoptotic concentrations of MSeA induced p21cip1 mRNA (3 h) and protein (6 h) much faster than p27kip1 mRNA (12 h) and protein (12 h). Knocking down of p21 by siRNA completely abolished G(1) arrest induction by MSeA in DU145 cells, yet si-p27 RNA had no attenuation effect on the G(1) arrest. Depletion of p21Cip1 alone or both p21Cip1 and p27Kip1 increased MSeA-induced caspase-mediated apoptosis. Immunoprecipitation detected increased binding of p21Cip1 to CDK2 and CDK6 in MSeA-exposed DU145 cells. In DU145 xenografts from mice acutely treated with MSeA p.o., the induction of p21Cip1 was observed at 72 h of daily exposure. In p53-wild type LNCaP PCa cells and p53-null PC-3 PCa cells, MSeA modestly and transiently upregulated p21Cip1 protein level, subsiding to basal level by 24 h, without affecting P27Kip1 abundance in the same duration. Si-p21 RNA knockdown in these cells have only a partial effect to reverse G(1) arrest induction by MSeA. Together, our data support persistent, p53-independent, p21Cip1 induction as a critical mediator of MSeA-induced G(1) arrest in DU145 PCa cells, however, p21Cip1 induction and G(1) arrest were not necessary for, and may antagonize, caspase-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370687     DOI: 10.2174/156800910791190238

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  9 in total

1.  Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.

Authors:  Yong Zhang; Suk-Hyun Won; Cheng Jiang; Hyo-Jeong Lee; Soo-Jin Jeong; Eun-Ok Lee; Jinhui Zhang; Min Ye; Sung-Hoon Kim; Junxuan Lü
Journal:  Pharm Res       Date:  2012-01-27       Impact factor: 4.200

2.  Methylseleninic acid suppresses pancreatic cancer growth involving multiple pathways.

Authors:  Lei Wang; Hongbo Hu; Zhe Wang; Hua Xiong; Yan Cheng; Joshua Dezhong Liao; Yibin Deng; Junxuan Lü
Journal:  Nutr Cancer       Date:  2014-01-21       Impact factor: 2.900

3.  Leishmanicidal activities of novel methylseleno-imidocarbamates.

Authors:  Celia Fernández-Rubio; Daphne Campbell; Andrés Vacas; Elena Ibañez; Esther Moreno; Socorro Espuelas; Alfonso Calvo; Juan Antonio Palop; Daniel Plano; Carmen Sanmartin; Paul A Nguewa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

4.  Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.

Authors:  Yong Zhang; Kwan-Hyun Kim; Wei Zhang; Yinglu Guo; Sung-Hoon Kim; Junxuan Lü
Journal:  Int J Cancer       Date:  2011-05-09       Impact factor: 7.396

5.  Association of mutation and hypermethylation of p21 gene with susceptibility to breast cancer: a study from north India.

Authors:  Naseem Akhter; Md Salman Akhtar; Md Margoob Ahmad; Shafiul Haque; Sarah Siddiqui; Syed Ikramul Hasan; Nootan K Shukla; Syed Akhtar Husain
Journal:  Mol Biol Rep       Date:  2014-01-24       Impact factor: 2.316

6.  Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.

Authors:  Steffen Wedel; Lukasz Hudak; Jens-Michael Seibel; Jasmina Makarević; Eva Juengel; Igor Tsaur; Ana Waaga-Gasser; Axel Haferkamp; Roman A Blaheta
Journal:  BMC Cancer       Date:  2011-08-25       Impact factor: 4.430

7.  Antioxidant-prooxidant properties of a new organoselenium compound library.

Authors:  Daniel Plano; Ylenia Baquedano; Elena Ibáñez; Iosu Jiménez; Juan Antonio Palop; Julian E Spallholz; Carmen Sanmartín
Journal:  Molecules       Date:  2010-10-21       Impact factor: 4.411

8.  Novel library of selenocompounds as kinase modulators.

Authors:  Daniel Plano; Elena Ibáñez; Alfonso Calvo; Juan Antonio Palop; Carmen Sanmartín
Journal:  Molecules       Date:  2011-07-27       Impact factor: 4.411

Review 9.  Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy.

Authors:  Carmen Sanmartín; Daniel Plano; Arun K Sharma; Juan Antonio Palop
Journal:  Int J Mol Sci       Date:  2012-08-02       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.